hM4Di-DREADD

N/A

Report date: 2025/03/20 15:14:44
NME

Base Information

Drug NamehM4Di-DREADD
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transduction pathway inhibitors
TargetsUpdating
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCincinnati Children'S Hospital Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State University Wexner Medical CenterCincinnati Children'S Hospital Medical Center
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A